Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Anti-infectives Market

Veterinary Anti-infectives Market Share

Report ID: GMI12126
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Veterinary Anti-infectives Market Share

The market is characterized by the presence of several key players, including multinational pharmaceutical companies and specialized veterinary companies. Major companies focus on research and development to innovate and expand their product offerings, targeting both livestock and companion animals. Furthermore, strategic collaborations, mergers, and acquisitions are common as firms seek to enhance their market presence and diversify their portfolios. Additionally, companies are increasingly emphasizing sustainable practices and responsible antibiotic use to address rising concerns about antibiotic resistance, further shaping the competitive dynamics within the market.

Veterinary Anti-infectives Market Companies

Few of the prominent players operating in the veterinary anti-infectives industry include:

Aspen Veterinary Resources
Boehringer Ingelheim International
Ceva
Dechra Pharmaceuticals
Elanco
Merck & Co
Norbrook
Phibro Animal Health
Vetoquinol S.A.
Virbac
Zoetis

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The veterinary anti-infectives industry was valued at USD 5.4 billion in 2023 and is estimated to grow at a 3.5% CAGR from 2024 to 2032, driven by the increasing incidence of infectious diseases in livestock and companion animals.

The livestock animals segment accounted for the largest revenue in 2023 and is expected to maintain its dominance with a 3.4% CAGR through the forecast period, due to the growing need for disease prevention and management in large-scale animal farming.

U.S. veterinary anti-infectives industry was valued at USD 2 billion in 2023 and is anticipated to show considerable growth over the analysis period, driven by advanced healthcare infrastructure, substantial R&D investments, and a high prevalence of infectious diseases.

Key players in the market include Aspen Veterinary Resources, Boehringer Ingelheim International, Ceva, Dechra Pharmaceuticals, Elanco, Merck & Co, Norbrook, Phibro Animal Health, Vetoquinol S.A., Virbac, and Zoetis.